Search - tctmd.com

Displaying 261 - 280 of 1385

Sort: Relevancy | Date

Presentation TCT 2016

Controversy 4. Will the Minimalist Strategy Dominate TAVR in the Future: Supportive Clinical and Economic Data

Presenter: Raj Makkar, Lars Sondergaard, Ganesh Manoharan

October 31, 2016

Presentation TCT 2016

Indirect Annuloplasty via the Coronary Sinus II: MVRx

Presenter: Ted Feldman, Scott Lim, David Hildick-Smith

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Presenter: Niall T. Mulvihill, Hellmuth Weich

October 31, 2016

Presentation TCT 2016

Indirect Annuloplasty via the Coronary Sinus I: Updated Carillon Results and Future Plans

Presenter: Ted Feldman, Scott Lim, Samir R. Kapadia

October 31, 2016

Presentation TCT 2016

Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience

Presenter: Raj Makkar, Lars Sondergaard, John G. Webb

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Presenter: Niall T. Mulvihill, Antoniette Neylon

October 31, 2016

Presentation TCT 2016

Trialign for Functional TR: Early US Experience

Presenter: Eric Horlick, Josep Rodés-Cabau, Charles J. Davidson

October 31, 2016

Presentation TCT 2016

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Presenter: Niall T. Mulvihill

October 31, 2016

Presentation TCT 2016

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

Presenter: Harsimran Sachdeva Singh, John P. Breinholt

October 31, 2016

Presentation TCT 2016

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

Presenter: Raj Makkar, Lars Sondergaard, Helene Eltchaninoff

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty VI: Cardiac Implants

Presenter: Ted Feldman, Scott Lim, Karl-Heinz Kuck

October 31, 2016

Presentation TCT 2016

Controversy 3. Surgical Perspectives on Late Bioprosthetic Valve Durability

Presenter: Raj Makkar, Lars Sondergaard, A. Pieter Kappetein

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty V: Valcare

Presenter: Ted Feldman, Scott Lim, David Meerkin

October 31, 2016

Presentation TCT 2016

Flash Debate: Counterpoint 4D-CT Leaflet Imaging Findings Will Help to Direct Anticoagulation Therapy!

Presenter: Raj Makkar, Lars Sondergaard

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty IV: Millipede

Presenter: Ted Feldman, Scott Lim, Jason H. Rogers

October 31, 2016

Presentation TCT 2016

Flash Debate: Point 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance!

Presenter: Raj Makkar, Lars Sondergaard, Ganesh Manoharan

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty III: Guided Delivery Systems Results, Device Iterations, and Future Directions

Presenter: Ted Feldman, Scott Lim, Horst Sievert

October 31, 2016

Presentation TCT 2016

Controversy 2. Global Clinical Trial Experiences on Bioprosthetic Leaflet Thickening/Thrombosis: Updates and Insights

Presenter: Raj Makkar, Lars Sondergaard

October 31, 2016

Presentation TCT 2016

Direct Annuloplasty II: Mitralign Trial Results and Future Directions

Presenter: Ted Feldman, Scott Lim, Azeem Latib

October 31, 2016

Presentation TCT 2016

Flash Debate: Counterpoint Cerebral Protection Is an Unnecessary and Costly Accessory!

Presenter: Raj Makkar, Lars Sondergaard, Haim Danenberg

October 31, 2016

Advertisement

Controversy 4. Will the Minimalist Strategy Dominate TAVR in the Future: Supportive Clinical and Economic Data

Indirect Annuloplasty via the Coronary Sinus II: MVRx

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Con Position

Indirect Annuloplasty via the Coronary Sinus I: Updated Carillon Results and Future Plans

Late (>5 years) Clinical and Echo Outcomes After TAVR II: The Vancouver Experience

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Trialign for Functional TR: Early US Experience

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Congenital Heart Disease: PFO, ASD, PDA and Coarctation

Late (>5 years) Clinical and Echo Outcomes After TAVR I: The Rouen Experience

Direct Annuloplasty VI: Cardiac Implants

Controversy 3. Surgical Perspectives on Late Bioprosthetic Valve Durability

Direct Annuloplasty V: Valcare

Flash Debate: Counterpoint 4D-CT Leaflet Imaging Findings Will Help to Direct Anticoagulation Therapy!

Direct Annuloplasty IV: Millipede

Flash Debate: Point 4D-CT Leaflet Thickening Is an Imaging Curiosity With No Clinical Relevance!

Direct Annuloplasty III: Guided Delivery Systems Results, Device Iterations, and Future Directions

Controversy 2. Global Clinical Trial Experiences on Bioprosthetic Leaflet Thickening/Thrombosis: Updates and Insights

Direct Annuloplasty II: Mitralign Trial Results and Future Directions

Flash Debate: Counterpoint Cerebral Protection Is an Unnecessary and Costly Accessory!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content